149 related articles for article (PubMed ID: 2006181)
21. Selective alteration of mitochondrial function by Ditercalinium (NSC 335153), a DNA bisintercalating agent.
Esnault C; Brown SC; Segal-Bendirdjian E; Coulaud D; Mishal Z; Roques BP; Le Pecq JB
Biochem Pharmacol; 1990 Jan; 39(1):109-22. PubMed ID: 2297352
[TBL] [Abstract][Full Text] [Related]
22. Bisintercalation of ditercalinium into a d[CpGpCpG]2 minihelix: structure and dynamics aspects--a 400-MHz 1H-NMR study.
Delbarre A; Delepierre M; Langlois d'Estaintot B; Igolen J; Roques BP
Biopolymers; 1987 Jul; 26(7):1001-33. PubMed ID: 3620572
[No Abstract] [Full Text] [Related]
23. 1H and 31P nuclear magnetic resonance studies of the differences in DNA deformation induced by anti-tumoral 7H-pyrido[4,3-c]carbazole dimers.
Delepierre M; Maroun R; Garbay-Jaureguiberry C; Igolen J; Roques BP
J Mol Biol; 1989 Nov; 210(1):211-28. PubMed ID: 2585517
[TBL] [Abstract][Full Text] [Related]
24. DNase I susceptibility of bent DNA and its alteration by ditercalinium and distamycin.
Mendoza R; Markovits J; Jaffrezou JP; Muzard G; Le Pecq JB
Biochemistry; 1990 May; 29(21):5035-43. PubMed ID: 2198937
[TBL] [Abstract][Full Text] [Related]
25. Induction of DNA bending by bifunctional intercalating agents of the 7H-pyridocarbazole family.
Maroun RC; Roques BP
Biophys Chem; 1991 Jan; 39(1):45-56. PubMed ID: 2012833
[TBL] [Abstract][Full Text] [Related]
26. Cytokinetic effects of bifunctional antitumor intercalator ditercalinium on Friend erythroleukemia cells.
Traganos F; Bueti C; Melamed MR; Darzynkiewicz Z
Leukemia; 1987 May; 1(5):411-6. PubMed ID: 3478539
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of action of bisimidazoacridones, new drugs with potent, selective activity against colon cancer.
Hernandez L; Cholody WM; Hudson EA; Resau JH; Pauly G; Michejda CJ
Cancer Res; 1995 Jun; 55(11):2338-45. PubMed ID: 7757985
[TBL] [Abstract][Full Text] [Related]
28. X-Ray diffraction analyses of the natural isoquinoline alkaloids Berberine and Sanguinarine complexed with double helix DNA d(CGTACG).
Ferraroni M; Bazzicalupi C; Bilia AR; Gratteri P
Chem Commun (Camb); 2011 May; 47(17):4917-9. PubMed ID: 21431128
[TBL] [Abstract][Full Text] [Related]
29. Intercalative binding of ditercalinium to d(CpGpCpG)2: a theoretical study.
Maroun R; Delepierre M; Roques BP
J Biomol Struct Dyn; 1989 Dec; 7(3):607-21. PubMed ID: 2627301
[TBL] [Abstract][Full Text] [Related]
30. Interactions of antitumor drug ditercalinium with nucleic acids in solutions and in situ.
Kapuscinski J; Traganos F; Darzynkiewicz Z
Cancer Lett; 1988 Nov; 42(3):185-91. PubMed ID: 3191470
[TBL] [Abstract][Full Text] [Related]
31. Tight binding of the antitumor drug ditercalinium to quadruplex DNA.
Carrasco C; Rosu F; Gabelica V; Houssier C; De Pauw E; Garbay-Jaureguiberry C; Roques B; Wilson WD; Chaires JB; Waring MJ; Bailly C
Chembiochem; 2002 Dec; 3(12):1235-41. PubMed ID: 12465032
[TBL] [Abstract][Full Text] [Related]
32. Influence of aglycone modifications on the binding of anthracycline drugs to DNA: the molecular structure of idarubicin and 4-O-demethyl-11-deoxydoxorubicin complexed to d(CGATCG).
Gao YG; Wang AH
Anticancer Drug Des; 1991 Jul; 6(3):137-49. PubMed ID: 1872945
[TBL] [Abstract][Full Text] [Related]
33. Solution structure of a DNA complex with the fluorescent bis-intercalator TOTO modified on the benzothiazole ring.
Petersen M; Jacobsen JP
Bioconjug Chem; 1998; 9(3):331-40. PubMed ID: 9576807
[TBL] [Abstract][Full Text] [Related]
34. Structural perturbations in DNA caused by bis-intercalation of ditercalinium visualised by atomic force microscopy.
Berge T; Jenkins NS; Hopkirk RB; Waring MJ; Edwardson JM; Henderson RM
Nucleic Acids Res; 2002 Jul; 30(13):2980-6. PubMed ID: 12087184
[TBL] [Abstract][Full Text] [Related]
35. A novel form of intercalation involving four DNA duplexes in an acridine-4-carboxamide complex of d(CGTACG)(2).
Adams A; Guss JM; Collyer CA; Denny WA; Wakelin LP
Nucleic Acids Res; 2000 Nov; 28(21):4244-53. PubMed ID: 11058124
[TBL] [Abstract][Full Text] [Related]
36. Crystal structure of the 2:1 complex between d(GAAGCTTC) and the anticancer drug actinomycin D.
Kamitori S; Takusagawa F
J Mol Biol; 1992 May; 225(2):445-56. PubMed ID: 1593629
[TBL] [Abstract][Full Text] [Related]
37. Theoretical design, chemical synthesis and footprinting analysis of a novel peptide derivative of the intercalator 7-H pyridocarbazole targeted towards the major groove of DNA.
Gresh N; René B; Hui XW; Barsi MC; Roques BP; Garbay C
J Biomol Struct Dyn; 1994 Aug; 12(1):091-110. PubMed ID: 7848561
[TBL] [Abstract][Full Text] [Related]
38. Relationship between the size and position of substituents on 7H-pyrido[4,3-c]carbazole monomers and dimers and their DNA binding and anti-tumor properties.
Léon P; Garbay-Jaureguiberry C; Le Pecq JB; Roques BP
Anticancer Drug Des; 1988 Jun; 3(1):1-13. PubMed ID: 3382504
[TBL] [Abstract][Full Text] [Related]
39. Dynamics and thermodynamics of the counterion effect in a 7H-pyridocarbazole dimer (ditercalinium). Hypothesis of a nonbisintercalative binding mode to calf thymus DNA at high drug/base ratio.
Dodin G
J Med Chem; 1989 May; 32(5):1127-34. PubMed ID: 2709378
[TBL] [Abstract][Full Text] [Related]
40. 1H NMR studies of the bis-intercalation of a homodimeric oxazole yellow dye in DNA oligonucleotides.
Johansen F; Jacobsen JP
J Biomol Struct Dyn; 1998 Oct; 16(2):205-22. PubMed ID: 9833661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
